Treatment Type Did Not Change Prostate Cancer Survival in UK Trial.

Results from a trial involving 1643 men in the UK aged 50 to 69 years with localized prostate cancer showed that, after 15 years of follow-up, deaths from prostate cancer were similarly low among patients randomized to receive active monitoring of their tumors, a prostatectomy, or radiotherapy.